Home/Arcus Biosciences/David Lacey, MD
DL

David Lacey, MD

Board of Directors Member

Arcus Biosciences

Therapeutic Areas

Arcus Biosciences Pipeline

DrugIndicationPhase
CasdatifanLate-line Kidney CancerPhase 3
Inflammation ProgramsNot SpecifiedNot Specified